MFCSF
Price
$10.99
Change
-$0.03 (-0.27%)
Updated
Dec 18 closing price
84 days until earnings call
ORPEF
Price
$14.22
Change
+$0.37 (+2.67%)
Updated
Jul 22 closing price
Ad is loading...

MFCSF vs ORPEF

Header iconMFCSF vs ORPEF Comparison
Open Charts MFCSF vs ORPEFBanner chart's image
Medical Facilities
Price$10.99
Change-$0.03 (-0.27%)
Volume$6.11K
CapitalizationN/A
Orpea ACT
Price$14.22
Change+$0.37 (+2.67%)
Volume$400
CapitalizationN/A
MFCSF vs ORPEF Comparison Chart
Loading...
MFCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MFCSF vs. ORPEF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFCSF is a Hold and ORPEF is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (MFCSF: $10.99 vs. ORPEF: $14.22)
Brand notoriety: MFCSF and ORPEF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: MFCSF: 83% vs. ORPEF: 100%
Market capitalization -- MFCSF: $164.47M vs. ORPEF: $125.6M
MFCSF [@Medical/Nursing Services] is valued at $164.47M. ORPEF’s [@Medical/Nursing Services] market capitalization is $125.6M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MFCSF’s FA Score shows that 3 FA rating(s) are green whileORPEF’s FA Score has 2 green FA rating(s).

  • MFCSF’s FA Score: 3 green, 2 red.
  • ORPEF’s FA Score: 2 green, 3 red.
According to our system of comparison, MFCSF is a better buy in the long-term than ORPEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MFCSF’s TA Score shows that 3 TA indicator(s) are bullish.

  • MFCSF’s TA Score: 3 bullish, 5 bearish.

Price Growth

MFCSF (@Medical/Nursing Services) experienced а -1.83% price change this week, while ORPEF (@Medical/Nursing Services) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.34%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.29%.

Reported Earning Dates

MFCSF is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Medical/Nursing Services (-4.34% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MFCSF($164M) has a higher market cap than ORPEF($126M). MFCSF has higher P/E ratio than ORPEF: MFCSF (23.87) vs ORPEF (14.73). ORPEF YTD gains are higher at: 1421900.100 vs. MFCSF (62.059). ORPEF has higher annual earnings (EBITDA): 961M vs. MFCSF (56M). ORPEF has more cash in the bank: 952M vs. MFCSF (35.3M). MFCSF has less debt than ORPEF: MFCSF (139M) vs ORPEF (12.1B). ORPEF has higher revenues than MFCSF: ORPEF (4.3B) vs MFCSF (433M).
MFCSFORPEFMFCSF / ORPEF
Capitalization164M126M130%
EBITDA56M961M6%
Gain YTD62.0591421900.1000%
P/E Ratio23.8714.73162%
Revenue433M4.3B10%
Total Cash35.3M952M4%
Total Debt139M12.1B1%
FUNDAMENTALS RATINGS
MFCSF vs ORPEF: Fundamental Ratings
MFCSF
ORPEF
OUTLOOK RATING
1..100
6646
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
32
Undervalued
PROFIT vs RISK RATING
1..100
15100
SMR RATING
1..100
386
PRICE GROWTH RATING
1..100
4256
P/E GROWTH RATING
1..100
2799
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MFCSF's Valuation (19) in the null industry is in the same range as ORPEF (32). This means that MFCSF’s stock grew similarly to ORPEF’s over the last 12 months.

MFCSF's Profit vs Risk Rating (15) in the null industry is significantly better than the same rating for ORPEF (100). This means that MFCSF’s stock grew significantly faster than ORPEF’s over the last 12 months.

ORPEF's SMR Rating (6) in the null industry is in the same range as MFCSF (38). This means that ORPEF’s stock grew similarly to MFCSF’s over the last 12 months.

MFCSF's Price Growth Rating (42) in the null industry is in the same range as ORPEF (56). This means that MFCSF’s stock grew similarly to ORPEF’s over the last 12 months.

MFCSF's P/E Growth Rating (27) in the null industry is significantly better than the same rating for ORPEF (99). This means that MFCSF’s stock grew significantly faster than ORPEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MFCSFORPEF
RSI
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
71%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
48%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
46%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
31%
Advances
ODDS (%)
Bullish Trend 15 days ago
68%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
64%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
54%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
N/A
View a ticker or compare two or three
Ad is loading...
MFCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
BJRI37.330.09
+0.24%
BJ's Restaurants
XPO157.94-0.26
-0.16%
XPO
MLCO6.34-0.11
-1.71%
Melco Resorts & Entertainment Limited
CISO1.54-0.08
-4.94%
CISO Global

MFCSF and

Correlation & Price change

A.I.dvisor tells us that MFCSF and LWSCF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MFCSF and LWSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MFCSF
1D Price
Change %
MFCSF100%
-2.26%
LWSCF - MFCSF
16%
Poorly correlated
N/A
HLYK - MFCSF
9%
Poorly correlated
N/A
ORPEF - MFCSF
3%
Poorly correlated
N/A
LTGHY - MFCSF
1%
Poorly correlated
-2.36%
KJFI - MFCSF
1%
Poorly correlated
N/A
More

ORPEF and

Correlation & Price change

A.I.dvisor tells us that ORPEF and HWAIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORPEF and HWAIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORPEF
1D Price
Change %
ORPEF100%
N/A
HWAIF - ORPEF
22%
Poorly correlated
-4.98%
HLYK - ORPEF
14%
Poorly correlated
-1.95%
MFCSF - ORPEF
3%
Poorly correlated
-0.27%
LWSCF - ORPEF
2%
Poorly correlated
-1.59%
RAFLF - ORPEF
2%
Poorly correlated
N/A
More